Eli Lilly (LLY) and Regeneron (REGN) among first companies selected for FDA initiative to speed review of new manufacturing facilities
#ELI LILLY & CO#LLY.US#REGENERON PHARMACEUTICALS INC#REGN.US#FDA#EQUITIES#US SESSION#BIOTECHNOLOGY#PHARMACEUTICALS#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#NASDAQ 100 INDEX#ELI LILLY AND CO#LLY#REGN#US EQUITIES